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Apoptosis in keratinocytes is required for epidermal
turnover, stratum corneum formation, and removal of
ultraviolet-damaged premalignant cells. Its role in mel-
anocyte homeostasis and transformation, on the other
hand, has not been de¢ned, although apoptosis resis-
tance is a commonly recognized feature of melanoma.
We examined the expression of apoptosis regulators in
melanocytes, keratinocytes, melanoma, and HaCat
cells. Melanocytic cells expressed relatively high levels
of Bcl-2, Bcl-XL, Mcl-1, C-IAP-1, C-IAP-2, XIAP, Li-
vin, and Apaf-1. The only apoptotic regulator that was
di¡erentially expressed in melanoma cells and not mel-
anocytes was Survivin, whereas Bax was expressed in
melanocytes but not in most melanoma lines. Keratino-
cytic cells, on the other hand, expressed high levels of
FLIP and were relatively de¢cient in Bcl-2 family pro-
teins. Levels of p53 were highest in HaCat cells and
some of the melanoma lines, and barely detectable in
melanocytes and keratinocytes. Next, susceptibility of
these cells types to apoptosis induced by ultraviolet B,
the tyrosine analog 4-tert-butylphenol, and cytotoxic
drugs was examined. Melanocytes were relatively
resistant to ultraviolet B, whereas keratinocytes were
unresponsive to 4-tert-butylphenol. Melanocytes and
keratinocytes were generally less susceptible than mela-
noma lines and HaCat cells to etoposide, cisplatin, and
staurosporine. Induction of apoptosis in these cell types
was generally associated with decreased levels of Mcl-1,
XIAP, and Livin, and increased levels of p53, whereas
levels of other apoptotic regulators were unaltered.
These results provide insights into the potential roles of
apoptosis in the function and transformation of epider-
mal melanocytes and keratinocytes. Key words: 4-tert-
butylphenol/Bcl-2/FLIP/keratinocyte, melanocyte/melanoma/
Survivin/ultraviolet. J Invest Dermatol 120:48 ^55, 2003
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poptosis, or programmed cell death, is critical for
epidermal homeostasis. Keratinocyte proliferation is
balanced by terminal di¡erentiation in the granular
layer that leads to nuclear fragmentation (Polakowska
et al, 1994) and caspase activation (Weil et al, 1999),
hallmarks of apoptosis. Apoptotic keratinocyte cell death also re-
sults in the formation of the stratum corneum (Ishida-Yamamoto
et al, 1999). In addition to these homeostatic functions in normal
skin, keratinocyte apoptosis also represents an important response
to environmental injury such as ultraviolet (UV) radiation.
Apoptosis of keratinocytes that have sustained UV-induced
DNA damage requires p53 and represents a key protective me-
chanism against squamous cell carcinoma by removing premalig-
nant cells that have acquired mutations (Ziegler et al, 1994).
By contrast, melanocytes represent a static component of the
epidermis and the role of apoptosis in basal melanocyte function
and melanocytic tumor formation has not been well character-
ized. Nevertheless, it is generally thought that acquisition of re-
sistance to apoptosis is important in the transition from normal
melanocyte to melanoma (Gilchrest et al, 1999). This notion is
supported by studies demonstrating apoptosis resistance of mela-
nocytic nevus cells compared with melanocytes in collagen gel
(Alanko et al, 1999) and resistance of melanoma cell lines to
drug-induced apoptosis (Li et al, 1998). Moreover, melanoma cells
in vivo demonstrate low levels of spontaneous apoptosis compared
with other tumor cell types (Mooney et al, 1995; Staunton and
Ga¡ney, 1995) and resistance to apoptosis is associated with in-
creased metastasis in animal models of melanoma (Glinsky et al,
1997). The poor prognosis for patients with advanced melanoma
generally results from lack of therapeutic response to conven-
tional chemotherapy (Koh, 1991). Most chemotherapeutic drugs
function by inducing apoptosis in malignant cells (Fisher, 1994),
and dysfunctional apoptosis is the most likely explanation
for drug resistance in melanoma (Grossman and Altieri, 2001;
Satyamoorthy et al, 2001).
The molecular basis for apoptosis resistance in melanoma has
been examined in previous studies, demonstrating in some cases
increased expression of apoptotic inhibitors or loss of pro-apop-
totic factors that may result in a dysfunctional apoptotic program
(reviewed in Grossman and Altieri, 2001).With respect to the ‘‘ex-
trinsic’’ pathway, initiated by binding of tumor necrosis factor or
related cytokines (i.e., tumor necrosis factor-related apoptosis-in-
ducing ligand) to cell surface death receptors leading to activation
of caspase-8 (Ashkenazi and Dixit, 1998), several groups have re-
ported defective death receptor signaling or downregulation in
melanoma cells (Gri⁄th et al, 1998; Thomas and Hersey, 1998;
Ugurel et al, 1999). In addition, the caspase-8 inhibitor FLIP
is highly expressed in melanoma (Irmler et al, 1997). There has
been considerable interest in the intracellular factors regulating
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the ‘‘intrinsic’’ pathway, initiated by mitochondrial cytochrome c
release and leading to activation of caspase-9 (Green and Reed,
1998). The anti-apoptotic Bcl-2, which blocks cytochrome c re-
lease (Adams and Cory, 1998), was found increased in melanoma
compared with melanocytes in some but not all studies (Cerroni
et al, 1995; Collins and White, 1995; Selzer et al, 1998; Tang et al,
1998). Similarly for Bcl-2-related proteins, the anti-apoptotic
Bcl-XL and Mcl-1 and the pro-apoptotic Bax have been reported
elevated in some but not all melanomas examined (Selzer et al,
1998; Tang et al, 1998). Deletion or inactivation by methylation of
Apaf-1, a cofactor for caspase-9 (Zou et al, 1997), has also been
described in melanoma (Soengas et al, 2001). It has previously
been reported (Grossman et al, 1999a) that Survivin, a newly re-
cognized inhibitor of apoptosis (IAP) protein (LaCasse et al, 1998)
that blocks caspase-9 (O’Connor et al, 2000), was found expressed
in melanoma but not normal melanocytes. Finally, another IAP
protein, Livin/ML-IAP, has also been detected in melanoma cells
but not melanocytes (Vucic et al, 2000). With the exception of
these particular IAP proteins and Bcl-2 (Morales-Ducret et al,
1995; Kim et al, 2000; van den Wijngaard et al, 2000), however,
there is little information on the expression of apoptotic regula-
tors in melanocytes.
In this study we examine the expression of apoptotic regula-
tory molecules and apoptotic responses in melanocytes, melano-
ma cells, and keratinocytes. We found that melanocytic and
keratinocytic cells exhibit di¡erent expression patterns of apopto-
sis regulatory proteins and di¡erential susceptibilities to various
apoptotic stimuli.
MATERIALS AND METHODS
Drugs and chemicals Cisplatin (Sigma, St Louis, MO) was dissolved
in dimethyl formamide and stored at 41C. Etoposide (Sigma) was
dissolved in dimethyl sulfoxide and stored at 201C. Staurosporine
(Sigma) was dissolved in dimethyl sulfoxide and stored at 41C. 4-tert-
butylphenol (4-TBP; Aldrich, Milwaukee,WI) was prepared monthly in
70% ethanol and stored at 201C.
Antibodies Rabbit polyclonal antibodies to the following apoptotic
regulators were purchased from Santa Cruz Biotechnology (Santa Cruz,
CA): Bcl-2 (n-19, sc-492), Mcl-1 (S-19, sc-819), Bcl-XL (H-62, sc-7195),
FLIPS/L (H-202, sc-8347), c-IAP-1 (h-83, sc-7943), c-IAP-2 (H-85, sc-
7944), and Bax (N-20). Mouse monoclonal anti-hILP/XIAP (clone 48)
was obtained from Transduction Laboratories (San Diego, CA). Mouse
monoclonal anti-p53 (Ab-6) was obtained from Calbiochem (San Diego,
CA). Rabbit anti-serum generated against Apaf-1 (clone 846) and Livin
were kindly provided by Dr Yuri Lazebnik (Cold Spring Harbor
Laboratory, Cold Spring Harbor, NY) and Dr Gary Kasof (AstraZeneca,
Worcester, MA), respectively. Puri¢ed rabbit polyclonal antibody
recognizing Survivin has been described previously (Grossman et al, 1999a).
Melanocytic cells Human melanoma lines YUSAC2, YUSIT1,
YUGEN8, and LOX (Grossman et al, 1999a) were maintained as
described previously. Normal human melanocytes were obtained from
discarded foreskins, as approved by the Institutional Review Board at the
University of Utah (no. 8476). Foreskins were collected in either
keratinocyte growth medium (KGM)-2 (Clonetics Corp., San Diego,
CA) or melanocyte medium consisting of Ham’s F10 (Gibco BRL, Grand
Island, NY) containing 7.5% heat-inactivated fetal calf serum (Gibco),
0.1 mM 3-isobutyl-1-methylxanthine (Sigma), 1 mM dibutyryl cyclic
adenosine monophosphate (Sigma), 1 mM sodium orthovanadate (Sigma),
2.5 nM cholera toxin (Sigma), 50 ng phorbol 12-myristate 13-acetate per
ml (Sigma), and 1% penicillin-streptomycin-glutamine (Gibco-BRL).
After scraping away excess fat and subcutaneous tissue, foreskins were
£oated dermis side down in 25 mg Dispase II per ml (Roche
Pharmaceuticals, Nutley, NJ) in phosphate-bu¡ered saline (PBS) at 41C
overnight. The epidermis was lifted o¡, placed in trypsin^
ethylenediamine tetraacetic acid solution (0.05% trypsin, 0.53 mM
ethylenediamine tetraacetic acid; Gibco-BRL) at 371C, and occasionally
agitated for 10 min. An equal volume of melanocyte medium was then
added, epidermal fragments were carefully removed, and the cell
suspension was pelleted, resuspended in melanocyte medium, and then
cultured in a humidi¢ed incubator with 5% CO2 at 371C. Over the ¢rst
48 h the cell suspension was triturated twice daily to break up cell clumps
and improve cell attachment. The medium was changed every 2^3 d. After
1wk, 0.4 mg G418 sulfate per ml (Gibco-BRL) and an equal volume of 1 M
sodium hydroxide were added to the medium for 48 h to eliminate
potentially contaminating ¢broblasts. Melanocytes were pigmented and
reacted with antibody to the melanocyte markers S-100 and Melan-A
(Dako, Carpinteria, CA) by immunohistochemistry (not shown). The
dibutyryl cyclic adenosine monophosphate was found dispensable for
melanocyte growth, and was omitted from the medium in later
experiments. Early passage (1^3) melanocytes were seeded at 3105 per
35 mm dish (Falcon 353001) 1 d prior to exposure to apoptosis-inducing
agents.
Keratinocytic cells The human keratinocyte line HaCat was
maintained as described previously (Grossman et al, 1999b). For the
preparation of normal human keratinocytes, foreskins were collected in
KGM-2 medium and an epidermal suspension was obtained by
trypsinization as above. Cells from two foreskins were pooled to increase
yield and plating density. After diluting 1 : 2 in soybean trypsin inhibitor
(10 mg per ml in PBS, Gibco-BRL), keratinocytes were pelleted, washed
once in KGM-2 medium, and transferred in KGM-2 to £asks (for lysate
preparation) or 35 mm dishes for apoptosis experiments. Cells were
incubated as above, and medium was changed every 2^3 d until cells were
used at 30^70% con£uency.
UVB irradiation Immediately prior to irradiation, cells were washed
with Dulbecco’s PBS (Gibco-BRL), 1 ml PBS was added, and dishes were
uncovered. The irradiation chamber contained four UVB lamps (FS20T12-
UVB, National Biological Corporation, Twinsburg, OH) that emit
wavelengths between 250 and 420 nm (72.6% UVB, 27.4% UVA, 0.01%
UVC), with peak emission at 313 nm, according to the manufacturer. A
¢lter (Kodacel K6808, Eastman Kodak, Rochester, NY) was placed over
the dishes to block residual UVC. Dosimetry was determined using a
newly calibrated UVB-500C meter (National Biological Corp.). The
irradiation rate was approximately 0.2 mJ per m2 per s. After UVB
exposure, the medium was replaced and the recovered dishes were
returned to the incubator.
Apoptosis detection Cells exposed to drugs or UVB were recovered by
trypsinization (including nonadherents), washed in PBS, resuspended in
cold 70% ethanol, and stored on ice. Apoptosis was assessed by DNA
content analysis as described previously (Grossman et al, 1999a). Brie£y,
cells were ethanol-¢xed and resuspended in staining solution consisting
of 25 mg propidium iodide per ml (Sigma), 0.05% Triton X-100, and
100 mg RNAse per ml (Gibco-BRL) in PBS. Flow cytometry was
performed on a FACScan (Becton Dickinson, San Jose, CA) using Cell
Quest software (Becton Dickinson).
Western blotting Cell lysates were prepared and protein content was
measured as described previously (Grossman et al, 1999a). Samples (25 mg)
were electrophoresed under reducing conditions at 200 V through a 5%
stacking and 15% resolving acrylamide gel, and transferred on to
Immobilon-P membranes (Millipore, Bedford, MA). Membrane blots
were placed in PBS containing 5% nonfat milk and 0.1% Tween-20, and
incubated at 41C overnight. Blots were then incubated 2 h at room
temperature in 5% nonfat milk and 0.1% Tween-20 containing primary
antibodies to Bcl-2 (0.2 mg per ml), Mcl-1 (0.2 mg per ml), Bcl-XL (0.5 mg
per ml), C-IAP-1 (0.5 mg per ml), C-IAP-2 (0.2 mg per ml), XIAP (0.25 mg
per ml), Survivin (0.5 mg per ml), Livin (1 : 3000 dilution), FLIP (0.5 mg per
ml), Apaf-1 (1 : 3000 dilution), p53 (0.1 mg per ml), or Bax (0.3 mg per ml).
After washing in PBS/Tween, blots were reacted with 1 : 10,000 dilution
horseradish peroxidase-conjugated goat anti-rabbit or goat anti-mouse
immunoglobulin (New England Nuclear, Boston, MA) in blocking
solution for 30 min at room temperature. After washing in PBS/Tween,
bands were visualized by enhanced chemiluminescence (Perkin-Elmer
Life Sciences Inc., Boston, MA) and autoradiography. To con¢rm
equivalent protein loading per lane, blots were subsequently washed and
reacted with a 1 : 10,000 dilution of (if previously exposed to rabbit
antibody) mouse anti-b-actin (clone AC-74, Sigma) or (if previously
exposed to mouse antibody) rabbit anti-b-actin (Sigma), and bands
visualized as above.
RESULTS
Expression of apoptosis regulators We assessed the expression
of a panel of apoptotic regulators in human melanocytes,
melanoma cells, keratinocytes, and the keratinocyte line HaCat
by western blotting. For melanocytes and keratinocytes, lysates
were independently prepared from three di¡erent donors given
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the possibility of individual-speci¢c e¡ects. We ¢rst examined
apoptotic inhibitors of the Bcl-2 family, negative regulators of
the mitochondrial apoptotic pathway. As shown in Fig 1(A),
Bcl-2 displayed a striking melanocytic-speci¢c pattern with
expression in all three melanocyte and four melanoma lines; it
was barely detected in two of three keratinocyte lines and absent
in HaCat cells.The Bcl-2 homolog Mcl-1was similarly present in
melanocytes and melanoma cells, and absent from keratinocytic
cells (Fig 1A). Bcl-XL, by contrast, was seen in all cell types
with strongest expression in the melanoma lines (Fig 1A). We
then looked at members of the IAP family of caspase inhibitors.
Both c-IAP1 and c-IAP2 were detected in all cell types, with
strongest expression seen in melanocytes and melanoma cells
and relatively weak expression in two of three keratinocyte lines
(Fig 1A). Expression of XIAP was greatest in the melanoma lines
and absent in HaCat cells, whereas melanocytes and keratinocytes
expressed low but comparable levels (Fig 1A). Survivin was
generally seen in only the transformed cells (three melanoma
lines and HaCat cells) and not in either melanocytes or
keratinocytes (Fig 1A), although low levels could be detected in
the fourth melanoma line (YUSIT1) and three of seven
melanocyte lines on overexposed blots (not shown). Livin, on
the other hand was found in all cell types, with relatively
weaker expression in two of three keratinocyte lines (Fig 1A).
The caspase-8 inhibitor FLIP was highly expressed in
keratinocytes, weakly expressed in HaCat cells, and notably
absent from both melanocytes and melanoma cells (Fig 1A).
Next, we examined expression of several pro-apoptotic
regulatory molecules. The tumor suppressor p53 was highly
expressed in two melanoma lines (YUSAC2, YUGEN8) and
relatively weakly expressed in all other cells (Fig 1B). The p53-
dependent caspase-9 cofactor Apaf-1 was strongly expressed in
melanocytes and melanoma cells, with keratinocytes
demonstrating relatively weak expression (Fig 1B). The Bcl-2
family member Bax was notably expressed in three melanocyte
lines and YUSIT1 melanoma cells, and absent from
keratinocytes (Fig 1B). Equivalent protein loading was
con¢rmed for each blot by staining for actin (Fig 1C). Thus
melanocytic cells expressed high levels of anti-apoptotic Bcl-2
and IAP family proteins, and the pro-apoptotic protein Apaf-1,
whereas keratinocytic cells expressed high levels of the anti-
apoptotic protein FLIP and were relatively de¢cient in Bcl-2
family proteins. These expression studies are summarized in
Table I.
Cell cycle analysis Given recent insights into the relationship
between apoptosis and cell cycle control (Evan and Vousden,
2001), we determined if there were any baseline di¡erences in
cell cycle progression or proliferation status among these cell
types prior to examining the di¡erential sensitivities of these
cell types to various apoptotic stimuli. Analysis of independent
subcultures of the cells used in these experiments, however, did
not reveal signi¢cant di¡erences (ANOVA, p40.05) in mitotic
(G2M) fractions among the melanocytic and keratinocytic cell
types (Fig 2). There was more variability in G1 fractions among
the cell types, with that of HaCat being relatively lower than the
rest (ANOVA, p¼ 0.001), suggesting a higher percentage of
HaCat cells may be in S phase.
Apoptotic responses to UVB UVB radiation is known to be
a potent physiologic inducer of apoptosis in keratinocytes, and we
con¢rmed that normal keratinocytes exhibited a obse-dependent
(30^120 mJ per cm2) apoptotic response, as determined by
nuclear propidium iodide staining and £ow cytometry, which
was maximal 24 h following UV exposure (Fig 3A). HaCat cells
were similarly sensitive to UV-induced apoptosis (Fig 3A).
Normal melanocytes, on the other hand, were markedly
resistant to UV-induced apoptosis, requiring 120 mJ per cm2 for
a maximal response that was not evident until 48 h following
exposure (Fig 3A). We also examined four melanoma cell lines
under these same conditions. As shown in Fig 3(B), peak
apoptotic responses for all melanoma lines were induced at doses
(60^120 mJ per cm2) comparable with that required by
keratinocytes and HaCat cells, but like melanocytes, were not
maximal until 48 h following UV exposure.
Apoptotic responses to 4-TBP Next, we examined apoptotic
responses to the tyrosine analog 4-TBP, previously shown to
induce apoptosis in melanocytes (Yang et al, 2000). Similarly, we
demonstrated that 4 -TBP (0.6^0.9 mM) readily induced apoptosis
in melanocytes with responses peaking 48 h after initial exposure
(Fig 4A). Keratinocytes, on the other hand, were unresponsive
(Fig 4A). There was some variability in both melanocyte and
keratinocyte responses to 4-TBP, particularly at the highest
concentration tested, due to an aberrant response of cells from
one of ¢ve individuals. HaCat cells were highly sensitive,
with maximal responses peaking at 24 h after initial exposure
(Fig 4A). As shown in Fig 4(B), the four melanoma lines were
acutely sensitive, responding to the lowest concentration (0.3 mM)
tested, and apoptotic responses at each dose were generally
maximal 24 h following initial exposure.
Figure1. Expression of apoptotic regulators. Cell lysates (25 mg) pre-
pared from subcon£uent cultures of melanocytes (MC, lanes 1^3), melano-
ma lines (YUSIT1, lane 4;YUSAC2, lane 5;YUGEN8, lane 6; LOX, lane 7),
keratinocytes (KC, lanes 8^10), and HaCat cells (lane 11) were subjected to
western blotting using a panel of antibodies against (A) apoptosis inhibi-
tors and (B) pro-apoptotic molecules as indicated. Approximate molecular
weights of reactive species are indicated. (C) Each blot was restained with
antibody to actin to con¢rm equivalent protein loading in each lane. A
representative blot is shown.
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Drug-induced apoptosis We then determined the
susceptibility of these cell types to several apoptosis-inducing
drugs, each thought to initiate apoptosis by distinct mechanisms.
Cells were separately incubated with increasing concentrations of
drug, and apoptotic responses measured at 24 and 48 h. First, cells
were exposed to etoposide (5^50 mM), which binds topoisomerase
II and blocks DNA religation. Melanocytes, keratinocytes, and
two of the melanoma lines (YUSAC2 and YUGEN8) were
generally unresponsive, whereas another (LOX) was minimally
responsive (Fig 5A). By contrast, the lowest concentration (5
mM) readily induced apoptosis in HaCat cells and the melanoma
lineYUSIT1 (Fig 5A). Second, cells were exposed to the DNA-
damaging agent cisplatin (10^90 mM). Keratinocytes and one
melanoma line (YUSAC2) responded poorly, whereas other cell
types exhibited moderate responses peaking 48 h after initial
exposure (Fig 5B). Finally, apoptotic responses to staurosporine
(0.2^2 mM), an inhibitor of phospholipid/calcium-dependent
protein kinase, were examined. Melanocytes, keratinocytes, and
YUSAC2 melanoma cells responded minimally, whereas all
other cell types exhibited robust responses generally peaking 24
h after initial exposure (Fig 5C). These responses are
summarized, along with the other apoptotic responses observed
in this study, inTable II.
Apoptotic regulators during apoptotic stimulation Finally,
we investigated potential relationships in these cells between
apoptosis induction and expression of apoptotic regulators. For
these experiments, we sought to examine each cell type under
conditions in which an apoptotic response would be initiated
but not maximal or complete. Based on the responses to
apoptotic stimuli described above, we chose to prepare lysates
from melanocytes, YUSAC2 melanoma cells, and keratinocytes
24 h after exposure to 95 mJ per cm2 UVB. Lysates were
simultaneously prepared from sham-treated cells to serve as
controls for baseline levels of apoptotic regulators. Two
Figure 2. Cell cycle analysis. Subcon£uent untreated cultures of mela-
nocytes (MC), keratinocytes (KC), HaCat cells, and melanoma lines (YU-
SIT1, YUSAC2, YUGEN8, LOX) were collected, ¢xed, stained with
propidium iodide, and analyzed by £ow cytometry. Data are expressed as
percent interphase (G1, open bars) and dividing (G2M, ¢lled bars) cells as
indicated. Error bars re£ect SEM from six independent subcultures.
Table I. Summary of relative expression of apoptotic regulatorsa
Melanocytes YUSIT1 YUSAC2 YUGEN8 LOX Keratinocytes HaCat
Bcl-2 þþ þþ þþ þþ 0 0 0
Mcl-1 þ þþ þþ þþ 0 0 0
Bcl-XL þ þþ þþ þþ þþ þ þ
C-IAP-1 þþ þþ þþ þþ þþ þ þþ
C-IAP-2 þþ þþ þþ þþ þþ þ þ
XIAP þ þþ þþ þþ þ þ 0
Survivin 0 0 þþ þþ þ 0 þ
Livin þ þþ þþ þþ þ þ þþ
FLIP 0 0 0 0 0 þþ þ
Apaf-1 þþ þþ þþ þþ þþ 0 þ
p53 0 0 þ þ 0 0 þþ
Bax þþ þþ 0 0 0 0 0
aSummary of relative expression of apoptotic regulators in untreated cultures of melanocytes, melanoma lines (YUSIT1,YUSAC2,YUGEN8, LOX), keratinocytes and
HaCat cells, as determined by western blotting in Fig 1. Expression scored as: 0, absent or barely detectable; þ, weak expression; or þþ , strong expression.
Figure 3. Melanocytes are resistant to UVB-induced apoptosis. (A)
Subcon£uent cultures of keratinocytes (KC), HaCat cells, and melanocytes
(MC) were exposed to increasing doses of UVB as indicated. Cells treated
at each dose were collected and ¢xed either 24 (open circles) or 48 h (¢lled
circles) after UV exposure. Data are expressed as percent apoptotic cells,
derived from the sub-G1 fraction obtained by £ow cytometry of propidium
iodide-stained cells. Error bars re£ect SEM from three independent experi-
ments, and cells (KC, MC) were derived from di¡erent donor foreskins for
each experiment. (B) Subcon£uent cultures of melanoma lines YUSIT1,
YUSAC2, YUGEN8, and LOX were treated and analyzed as in A above.
Error bars re£ect SEM from three independent experiments.
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experiments were performed, using melanocytes and
keratinocytes derived from di¡erent donors. In melanocytes,
UVB-induced apoptotic stimulation was associated with
reduced expression of Mcl-1, XIAP, and Livin, and induction of
p53 (Fig 6). Keratinocytes similarly exhibited reduced expression
of XIAP and Livin, and increased expression of p53. InYUSAC2
cells, UVB led to slightly decreased levels of Mcl-1, XIAP, Livin,
and p53 that were associated with the appearance of putative
breakdown products of 25^30 kDa (Fig 6). Levels of Bcl-2,
Bcl-XL, c-IAP1, c-IAP2, Survivin, FLIP, Apaf-1, and Bax were
not appreciably changed upon UVB exposure in any of the cell
types (not shown).
DISCUSSION
Apoptosis is known to be a key factor in keratinocyte homeosta-
sis and squamous cell carcinoma development, yet the role of cell
death in the maintenance and transformation of melanocytes is
poorly understood. To de¢ne the basic apoptotic programs in
these cell types, we have characterized their expression of apopto-
sis regulatory proteins and their responses to a variety of apopto-
tic stimuli. Consistent with their di¡erent functional roles, we
found that melanocytic and keratinocytic cells exhibit di¡erential
expression patterns of apoptotic regulators that correlate with dif-
ferent susceptibilities to apoptotic signals.
Several groups (Morales-Ducret et al, 1995; Kim et al, 2000; van
denWijngaard et al, 2000) had previously demonstrated Bcl-2 ex-
pression in melanocytes. These observations were con¢rmed, and
we also found that melanocytes expressed relatively high levels of
additional Bcl-2 family proteins Bcl-XL and Mcl-1, as well as the
pro-apoptotic Bax, whereas keratinocytic cells were relatively de-
¢cient in these proteins. Keratinocytic cells, in contrast to mela-
nocytic cells, expressed high levels of the anti-apoptotic protein
FLIP.We did not detect signi¢cant FLIP expression in either mel-
anocytes or melanoma cells, although Irmler et al (1997) reported
FLIP expression in both melanoma tumors and cell lines. In the
three of four melanoma lines examined, levels of Bcl-2 were
comparable with that in melanocytes, whereas both Mcl-1 and
Bcl-XLwere generally elevated. Bax was highly expressed in only
one of four melanoma lines. These ¢ndings are consistent with
previous expression studies in melanoma lesions on Bcl-2 (Selzer
et al, 1998; Tang et al, 1998), Bcl-XL (Selzer et al, 1998; Leiter et al,
Figure 4. Keratinocytes are unresponsive to 4-TBP-induced apop-
tosis. (A) Subcon£uent cultures of melanocytes (MC), keratinocytes
(KC), and HaCat cells were incubated with increasing doses of 4-TBP as
indicated. Cells treated at each dose were collected and ¢xed either 24
(open circles) or 48 h (¢lled circles) later. Percent apoptotic cells were de-
termined as in Fig 3. Error bars re£ect SEM from ¢ve independent experi-
ments, and cells (KC, MC) were derived from di¡erent donor foreskins for
each experiment. (B) Subcon£uent cultures of melanoma lines YUSIT1,
YUSAC2, YUGEN8, and LOX were treated and analyzed as in A above.
Error bars re£ect SEM from three independent experiments.
Figure 5. Drug-induced apoptosis. Subcon£uent cultures of (A) mela-
nocytes (MC), (B) keratinocytes (KC), (C) HaCat cells, and (D^G) melano-
ma lines YUSIT1, YUSAC2, YUGEN8, and LOX were exposed to
increasing concentrations of etoposide, cisplatin, or staurosporine as indi-
cated. Cells treated at each dose were collected and ¢xed either 24 (open
circles) or 48 h (¢lled circles) later. Percent apoptotic cells were determined
as in Fig 3. Error bars re£ect SEM from two or three independent experi-
ments, and cells (KC, MC) were derived from di¡erent donor foreskins for
each experiment.
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2000), Mcl-1 (Tang et al, 1998), and Bax (Selzer et al, 1998; Leiter
et al, 2000). Raisova et al (2001) have shown that susceptibility to
death receptor signaling in melanoma lines correlates with a high
Bax/Bcl-2 ratio.We did not observe such a correlation among the
lines studied here with sensitivity to various apoptotic stimuli,
but it is intriguing that the LOX melanoma line was responsive
to lower doses of UVB and cytotoxic drugs and was the only line
that did not express Bcl-2 or Mcl-1. Of all the apoptotic regula-
tors examined, Bax was the only protein consistently expressed
in melanocytes and not melanoma cells.
Melanocytic cells also consistently expressed multiple IAP
proteins, including C-IAP-1, C-IAP-2, XIAP, and Livin. The
c-IAP proteins were expressed at roughly equivalent levels in
melanocytes and melanoma cells, whereas XIAP and Livin were
found at higher levels in melanoma cells compared with melano-
cytes. Initial studies (Vucic et al, 2000; Kasof and Gomes, 2001) on
Livin (or ML-IAP) noted expression in melanoma cells but not
melanocytes (Vucic et al, 2000). Our ability to detect Livin ex-
pression in melanocytes may be due to our use of a polyclonal
reagent that would be expected to react with both isoforms that
have been reported (Ashhab et al, 2001). Consistent with previous
work (Grossman et al, 1999a), the only apoptotic regulator that
was generally expressed in melanoma cells and not melanocytes
was the IAP protein Survivin, suggesting that it may be impor-
tant at a relatively later stage in melanocyte transformation.
The pro-apoptotic protein p53 was highly expressed in HaCat
cells and two of the melanoma lines, but not in either melano-
cytes or keratinocytes. High levels of p53 generally re£ect mutant
protein, and it is known that both alleles of the p53 gene are mu-
tated in HaCat cells (Lehman et al, 1993). It is likely that p53 mu-
tation accounts for the high levels detected in YUSAC2 and
YUGEN8 melanoma lines. Finally, although Soengas et al (2001)
reported loss of Apaf-1 in melanoma lesions and 10 of 19 melano-
ma lines, we found Apaf-1 consistently expressed in both mela-
nocytes and all four melanoma cell lines.
UVB radiation is the primary mutagen involved in nonmela-
noma skin cancer (Grossman and Le¡ell, 1997) and a physiologic
apoptotic stimulus. Most premalignant keratinocytes with UVB-
induced mutations are eliminated rapidly by apoptosis, or lost
slowly through normal epidermal turnover. Consistent with this
scenario and previous observations (Jost et al, 2001), UVB pro-
duced a rapid apoptotic response in both normal keratinocytes
and the keratinocyte line HaCat. By comparison, we found that
normal melanocytes were relatively resistant to UVB-induced
apoptosis. Notable distinctions between keratinocytes and mela-
nocytes are that the former are present in large numbers and
chronically renewed in the epidermis, whereas the latter
sparsely populate the epidermis and are thought to be long-lived
(Gilchrest et al, 1999). Melanocytes could be viewed as less dispen-
sable than keratinocytes, and thus it makes teleologic sense that
they would have a much higher threshold than keratinocytes for
UVB-induced apoptosis.
The blunted apoptotic response of melanocytes to UVB was
not indicative of resistance to all apoptotic stimuli, as these cells
were quite sensitive to 4-TBP-induced apoptosis.We found that
normal keratinocytes, on the other hand, were refractory to 4-
TBP, consistent with a previous report (Yang et al, 2000). Yang
et al (2000) also ¢rst reported that melanocyte cytotoxicity
induced by 4-TBP represented apoptotic cell death, demonstrat-
ing DNA fragmentation and phosphatidylserine relocalization
in melanocytes exposed to 4-TBP. Depigmenting agents, such as
4-TBP, were originally proposed to act as substrates for tyrosi-
nase (McGuire and Hendee, 1971). The mechanism by which
4-TBP induces apoptosis in melanocytes, however, is unclear
and apparently not mediated by tyrosinase (Yang et al, 2000).
The A2b adenosine receptor may be involved, as Le Poole et al
(1999) showed it is upregulated in 4-TBP-treated melanocytes
and not keratinocytes.
A curious feature of both UVB and 4-TBP apoptotic responses
is that melanoma and HaCat cells were more sensitive, respec-
tively, than normal melanocytes and keratinocytes. This was
Table II. Summary of cell sensitivity to apoptotic stimulia
Keratinocytes HaCat Melanocytes YUSIT1 YUSAC2 YUGEN8 LOX
UVB þþ þþþ þ þþ þþ þþ þþ
4-TBP 0 þ þþ þþþ þþþ þþþ þþþ
Etoposide 0 þþ 0 þþ 0 0 þ
Cisplatin 0 þþ þþ þþ þ þþ þþ
Staurosporine þ þþþ þ þþþ þ þþþ þþþ
aSummary of relative responses of melanocytes, keratinocytes, HaCat cells, and melanoma lines (YUSIT1, YUSAC2, YUGEN8, LOX) to various apoptotic stimuli
examined in this study. Responses to UVB and 4-TBP are derived from Figs 3 and 4, respectively. Responses to etoposide, cisplatin, and staurosporine are derived from
Fig 5. Apoptotic response scored as: 0, no response at 24 h; þ, weak response peaking at 48 h; þþ, moderate response peaking at 48 h; or þþþ , strong response
peaking at 24 h.
Figure 6. Expression of apoptotic regulators during apoptotic in-
duction. Cell lysates (25 mg), prepared from subcon£uent cultures of mel-
anocytes (MC), YUSAC2 melanoma cells (YUS), and keratinocytes (KC)
24 h following sham treatment () or exposure to 95 mJ per cm2 UVB
(+), were subjected to western blotting for apoptosis inhibitors and pro-
apoptotic molecules as indicated. Adequate visualization of the Livin blot
for keratinocytes required relatively longer exposure time than that for
melanocytes and YUSAC2, thus optimal exposures are shown for each.
Approximate molecular weights of reactive species are noted. Blots were
restained with antibody to actin to con¢rm equivalent protein loading in
each lane. A representative blot is shown. Results are representative of two
independent experiments performed.
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somewhat unexpected, as we would have predicted that the
malignant cells would be more resistant to these apoptotic stimuli
than the untransformed cells fromwhich they were derived. One
possibility is that long-term culture of cell lines selects for clones
with a proliferative advantage in vitro that may be attained at the
expense of apoptotic resistance. The mechanistic basis for in-
creased susceptibility to UVB/4-TBP-induced apoptosis in mela-
noma and HaCat cells is unclear, however, as we did not
consistently ¢nd increased expression of pro-apoptotic molecules
or decreased expression of apoptotic inhibitors compared with
normal melanocytes and keratinocytes. Similarly, HaCat cells
were consistently more sensitive to drug-induced apoptosis than
normal keratinocytes. When comparing drug responses of the
melanoma cell lines with normal melanocytes, on the other
hand, no consistent pattern emerged. For example, two of four
melanoma lines responded to etoposide, whereas melanocytes
were unresponsive; melanocytes responded better to cisplatin
than two of the four melanoma lines tested; and ¢nally, three of
the four melanoma lines responded better to staurosporine than
did melanocytes. The susceptibility of these cell types to drug-in-
duced apoptosis was not related to the number of proliferating
cells in culture, as they displayed comparable G2M fractions de-
spite very disparate responses.
The expression and activity of apoptotic regulatory proteins
maintains a critical balance in cells, with anti-apoptotic and pro-
apoptotic regulators potentially exerting in£uence at multiple
control points in apoptotic pathways. Although melanocytes and
keratinocytes displayed almost reciprocal expression patterns for
many of these proteins, we found that apoptotic stimulation had
similar e¡ects in both. Speci¢cally, UVB exposure in both cell
types was associated with downregulation of two apoptotic inhi-
bitors (XIAP and Livin) and upregulation of a pro-apoptotic mo-
lecule (p53). Thus these changes are consistent with the known
functional activities of these particular regulatory proteins. It is
intriguing that only selected members of the IAP family, namely
XIAP and Livin, were altered, whereas others such as the C-IAPs
and Survivin were not. Similarly, it is unclear why apoptotic sti-
mulation of melanocytes, for example, would result in selective
reduction in Mcl-1without a¡ecting other Bcl-2 family proteins.
It is interesting that in YUSAC2 cells, UVB exposure was asso-
ciated with what appears to be limited proteolysis or cleavage of
these regulators, as was recently described for XIAP in tumor ne-
crosis factor-related apoptosis-inducing ligand-stimulated mela-
noma cells (Zhang et al, 2001). It is also possible that the lower
band in these blots may represent induction of smaller cross-reac-
tive proteins.
In conclusion, the di¡erences reported here between melano-
cytes and keratinocytes, with respect to expression of apoptotic
regulators and apoptotic responses, suggest that these cell
types are endowed with di¡erent apoptotic programs to meet
di¡erent functional needs in the skin. The relative de¢ciency
of apoptotic inhibitors in keratinocytes may maintain a low
apoptotic threshold that is required to sustain rapid turnover
and e⁄ciently remove damaged cells. The broad expression of
apoptotic inhibitors in melanocytes, on the other hand, may
serve to maintain their longevity, but this could come at the
expense of retaining damaged cells with the potential of
developing into melanoma. Our data do not support the notion
of reduced susceptibility to apoptosis in the progression
from melanocyte to melanoma, but rather suggest that the
apoptosis resistance characteristic of melanoma clinically may
merely re£ect an anti-apoptotic state that is well established
in precursor melanocytes. The ability to precipitate apoptosis,
however, in malignant melanocytes and keratinocytes by
expressing p53 (Yamashita et al, 2001) or Apaf-1 (Soengas et al,
2001), or by blocking individual apoptosis inhibitors of
either the Bcl-2 (Olie et al, 2002) or IAP (Grossman et al,
1999a; Grossman et al, 1999b; Kasof and Gomes, 2001) families,
suggests that the apoptotic balance in these cells is easily
perturbed and thus could potentially be exploited for therapeutic
gain.
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